Stavros G. Drakos

Interventional Cardiology

85 N Medical Dr
Salt Lake City, UT 84112

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 252 publications

Excessive EFHD1-dependent ER-mitochondrial contacts drive a maladaptive antiviral response in metabolic liver disease.

Excessive EFHD1-dependent ER-mitochondrial contacts drive a maladaptive antiviral response in metabolic liver disease.

Journal: The Journal of clinical investigation

Published: August 25, 2026

Microcurrent Therapy in Cardiac Repair: Bridging Mechanistic Biology and Clinical Evidence.

Microcurrent Therapy in Cardiac Repair: Bridging Mechanistic Biology and Clinical Evidence.

Journal: Circulation. Heart failure

Published: August 19, 2026

Single-cell multiomics and chromatin structure reveal gene-regulatory dynamics in heart failure.

Single-cell multiomics and chromatin structure reveal gene-regulatory dynamics in heart failure.

Journal: Science (New York, N.Y.)

Published: July 23, 2026

Splanchnic Vein Doppler After Left Ventricular Assist Device Implantation: A Bedside Tool for Assessing Decongestion and Organ Recovery.

Splanchnic Vein Doppler After Left Ventricular Assist Device Implantation: A Bedside Tool for Assessing Decongestion and Organ Recovery.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: July 14, 2026

Cardiorenal Syndrome and Depressive Symptoms: Exploring the Mood-Kidney Link With Heart Failure Risk in a Post-hoc Analysis of SPRINT.

Cardiorenal Syndrome and Depressive Symptoms: Exploring the Mood-Kidney Link With Heart Failure Risk in a Post-hoc Analysis of SPRINT.

Journal: Kidney medicine

Published: June 30, 2026

Adipocyte Enhancer Binding Protein 1 (AEBP1) Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure.

Adipocyte Enhancer Binding Protein 1 (AEBP1) Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure.

Journal: Research square

Published: June 05, 2026

Extracellular matrix and cytoskeletal reverse remodeling pathways are key drivers of myocardial recovery following left ventricular assist device therapy.

Extracellular matrix and cytoskeletal reverse remodeling pathways are key drivers of myocardial recovery following left ventricular assist device therapy.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

Macrophages orchestrate the landscape of advanced cardiac allograft vasculopathy.

Macrophages orchestrate the landscape of advanced cardiac allograft vasculopathy.

Journal: Nature cardiovascular research

Published: May 18, 2026

Integrative Clinical-Molecular Modeling Identifies LRRN4CL as a Determinant of Structural and Functional Myocardial Improvement.

Integrative Clinical-Molecular Modeling Identifies LRRN4CL as a Determinant of Structural and Functional Myocardial Improvement.

Journal: bioRxiv : the preprint server for biology

Published: May 04, 2026

PERM1 Is Selectively Restored in Left Ventricular Assist Device-Mediated Myocardial Recovery in Heart Failure.

PERM1 Is Selectively Restored in Left Ventricular Assist Device-Mediated Myocardial Recovery in Heart Failure.

Journal: Journal of the American Heart Association

Published: April 29, 2026

Left ventricular assist device therapy in Poland: Growth, outcomes, and evolving paradigms in advanced heart failure care.

Left ventricular assist device therapy in Poland: Growth, outcomes, and evolving paradigms in advanced heart failure care.

Journal: Kardiologia polska

Published: April 21, 2026

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Journal: Heart failure reviews

Published: April 18, 2026

Showing 1-12 of 252

Last Updated: 09/26/2026